Almost one third of surveyed HIV providers in the U.S. in 2013 to 2014 used a CD4 threshold to initiate antiretroviral therapy.
Since 2012, the Department of Health and Human Services antiretroviral therapy (ART) guidelines have recommended treatment of persons infected with HIV regardless of CD4 count. How well are we doing in implementing those recommendations? Using data from the Medical Monitoring Project, investigators from the CDC surveyed a probability sample of the estimated 8257 HIV care providers (44.5% infectious diseases physicians and 30% other physicians).
Among the 1234 providers who returned the survey, 71.2% reported initiating ART regardless of CD4 count. Providers with ≤20 patients, those practicing in non–Ryan White funded clinics, and those who reported that pharmaceutical companies' patient assistance programs did not provide sufficient medicati…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)